'김갑성' 기자의 전체기사
-
Halia Therapeutics Strengthens Global Genomics Leaders…
New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and advances collaboration with the Department of Health – Abu Dhabi LEHI, Utah, Oct. 6, 2025 -- Halia Therapeutics (The Genetic Resilience Company), a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced the appointment of Paul Jones as Chief Strategy Officer & GM, International Markets. In this newly created role, Jones will focus on accelerating GENMOR-AI, the company's proprietary platform for identifying genetic mo
- 김갑성 기자
- 2025-10-06 20:15
-
Olympus and W. L. Gore & Associates Enter into International…
CENTER VALLEY, Pa., and HAMBURG, Germany, Oct. 6, 2025 -- Olympus Corporation, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, has entered into an international distribution agreement with the medical products business of U.S.-based W. L. Gore & Associates, Inc. (hereinafter Gore), a global materials science company that develops innovative products across diverse industries. The agreement allows Olympus to become the exclusive international distributor and have distribution rights of the GORE® VIABIL® Biliar
- 김갑성 기자
- 2025-10-06 15:00
-
FDA Lifts Clinical Hold on NUZ-001
Highlights: U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 IND supported by robust preclinical safety data and comprehensive manufacturing and quality information from the previously signed Elanco licensing agreement Expedites NUZ-001 as a platform molecule with pipeline expansion potential Positions Neurizon for accelerated regulatory pathways and future partnering opportunities MELBOURNE, Australia, Oct. 6, 2025
- 김갑성 기자
- 2025-10-06 14:06
-
Taiwan Pavilion Fostering Collaborative Innovation in AI, Rege…
TAIPEI, Oct. 6, 2025 -- The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO), an organization focused on fostering Taiwan's biotech ecosystem, announced today that it will lead a delegation of 16 biotech industry partners from Taiwan to participate in BioJapan 2025 (Yokohama, October 8-10, 2025). Taiwan's participation in BioJapan 2025, through the Taiwan Pavilion and delegation, will serve as an impactful forum to showcase the value that Taiwan's ecosystem can bring to Japanese companies in jointly realizing the future of biotech innovation. BPIPO's Partici
- 김갑성 기자
- 2025-10-06 07:15
-
Hong Kong Tech Startup Advances AI Lung Cancer Screen…
HONG KONG, Oct. 4, 2025 -- Caretia, a local tech startup based at Hong Kong Science Park, today announced that its AI-powered lung cancer screening platform has achieved initial milestones and entered a new phase of development. This progress aligns closely with the direction set out in the 2025 Policy Address, where Chief Executive Mr. John Lee indicated that the government would comprehensively enhance cancer prevention and diagnosis and specifically recommended launching AI-assisted lung cancer screening. According to data from the HK Cancer Online Resource Hub, lung cancer
- 김갑성 기자
- 2025-10-04 08:00
-
SI 그룹, 아젤리스와 신규 파트너십 통해 EMEA 지역 유통망 확대
-- 브렌탁과의 오랜 파트너십 보완하는 아젤리스와의 새로운 협력 관계로 SI 그룹의 고객 접근성 확대 기대 더 우드랜즈, 텍사스, 2025년 10월 4일 -- 세계적인 고성능 첨가제, 생산 공정 솔루션, 의약품, 유기화학물 중간체 개발사이자 제조사인 SI 그룹(SI Group)이 2일 유럽·중동·아프리카(EMEA) 지역에서 플라스틱 첨가제 유통망을 확장하기 위해 아젤리스(Azelis)와 새로운 파트너십을 체결했다고 밝혔다. 2026년 1월 1일부터 시작되는 이번 파트너십을 통해 SI 그룹은 영향력을 확대하고 맞춤형 솔루션 및 현지 지원을 통해 고객 서비스 역량을 강화할 예정이다. SI 그룹은 또 신뢰할 수 있는 유통 파트너인 브렌탁(Brenntag)과 2005년부터 이어온 협력을 EMEA 지역 일부 국가에서 계속 이어갈 계획이다. SI 그룹은 아젤리스와 브렌탁이 시장에서 가장 큰 영향력을 발휘할 수 있는 지역에 집중하기 위한 전략적 차원에서 양사와의 파트너십을 결정했다. SI 그룹은 양사의 영업 인력 역량, 기술 전문성, 창고 관리 능력을 활용해 고객의 제품 접근성과 고객 지원 서비스를 강화하
- 김갑성 기자
- 2025-10-03 23:26
-
Positioning Da Nang as Southeast Asia's Leading Medica…
DA NANG, Vietnam, Oct. 3, 2025 -- Da Nang is set to host the Da Nang Global Business Summit 2025 under the theme "Unlocking the Future of Medical & Wellness Tourism: Innovation – Creativity – Global Connectivity". The two-day event will take place on November 11–12, 2025, at Fusion Resort & Villas Da Nang, affirming the city's ambition to become a leading hub for medical tourism in the region. The summit is expected to welcome over 200 senior leaders and policymakers from international hospitals, technology corporations, tourism enterprises, and government age
- 김갑성 기자
- 2025-10-03 17:37
-
Prudential Health Partnership Networking Cocktail Reception b…
Over 200 representatives from hospitals and medical institutions, together with doctors, gathered to celebrate their shared achievements HONG KONG, Oct. 3, 2025 -- Prudential Hong Kong Limited ("Prudential") hosted the Health Partnership Networking Cocktail Reception yesterday at the JW Marriott Hotel Hong Kong. The event welcomed over 200 distinguished guests, including HKSAR Executive Council Member Dr. Ko Wing-man, alongside doctors and representatives from hospitals and medical institutions across Chinese mainland, Hong Kong, and Macau. The reception served as a d
- 김갑성 기자
- 2025-10-03 17:29
-
スターラボ、合弁事業の戦略的パートナーおよび株式所有者としてスペース・アプリケー…
宇宙インフラ、ペイロード統合、ミッション運用における欧州のリーダー、スターラボに参画。 ヒューストンおよびシドニー, 2025年10月3日 --Starlab Space LLCは本日、第76回国際宇宙会議において、ベルギーに拠点を置く宇宙工学およびペイロード統合のリーダー企業であるSpace Applications Servicesが、合弁事業パートナーおよび投資家として同社に加わったことを発表しました。このパートナーシップは、スターラボの世界的なフットプリントを拡大し、スターラボの顧客が利用できる機能を拡張する。 SpaceApps社は、航空電子工学、ペイロード開発、エンドツーエンドの国際商業実験キューブ（ICECubes）サービス、ミッション統合および運用管理ソフトウェアなどの機能を備え、宇宙システム、ミッション運用、ペイロード統合における深い経験に貢献している。同社はまた、欧州宇宙機関や国際的なパートナーとも緊密に協力し、スターラボの世界市場や研究コミュニティへのアクセスを広げている。 「投資家として、またパートナーとしてSpaceAppsを加えることは、私たちがデザインから現実へと急速に移行していることを証明するものです」とスターラボCEOのマーシャル・スミスは語った。「国際的なパートナーからの
- 김갑성 기자
- 2025-10-03 16:32
-
Mediso installs true theranostic TheraMAX SPECT/CT at Heide…
HEIDELBERG, Germany, Oct. 3, 2025 -- Mediso completes the installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear Medicine at Heidelberg University Hospital. The system is specifically designed for the clinical needs of theranostic imaging. Its detectors and collimators are developed for Targeted Radionuclide Therapies carried out with radioisotopes emitting alpha and beta particles and have co-emission of high and ultra-high energy gamma photons that are more challenging to image than diagnostic 99mTc. This requires maximized performance for
- 김갑성 기자
- 2025-10-03 16:12
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-21_TUE
- Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds 14:45
- Art Along the Silk Road in Shaanxi 13:46
- Headwolf Titan 1 -- 8.8" Gaming Tablet Built for Power 13:37
- Azentio's iMAL achieves exclusive AAOIFI certification for 2025, reinforcing its position as the world's leading Islamic Core Banking Platform 13:30
- Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention 13:12
- 글로벌 투자자와 기업 경영진, 오는 11월 제3회 바레인 게이트웨이 걸프 포럼에서 회동 12:20
- Xtep Launches Inaugural X-RUN CAMP for The Standard Chartered Heritage Marathon Hanoi in Vietnam 11:27
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 21일 16시 20분